Provided by Tiger Trade Technology Pte. Ltd.

Oncolytics Biotech Inc

1.06
-0.0400-3.64%
Post-market: 1.060.00000.00%19:56 EDT
Volume:708.39K
Turnover:766.01K
Market Cap:123.10M
PE:-3.53
High:1.10
Open:1.10
Low:1.06
Close:1.10
52wk High:1.51
52wk Low:0.3258
Shares:116.13M
Float Shares:114.00M
Volume Ratio:0.45
T/O Rate:0.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3000
EPS(LYR):-0.3000
ROE:-10187.64%
ROA:-170.96%
PB:-32.40
PE(LYR):-3.53

Loading ...

Top News Today: Stocks Rise Amid Hopes for Further U.S.-Iran Talks

Dow Jones
·
10 hours ago

Analysts Conflicted on These Healthcare Names: Oncolytics Biotech (ONCY) and Neurocrine (NBIX)

TIPRANKS
·
Apr 07

Oncolytics Biotech signs Jefferies ATM equity sale agreement for up to $75 million

Reuters
·
Apr 07

Oncolytics Biotech Inc - to Offer and Sell Common Stock up to $75 Mln Through Jefferies - SEC Filing

THOMSON REUTERS
·
Apr 07

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Norfolk Southern, Denali

Reuters
·
Apr 07

BUZZ-U.S. STOCKS ON THE MOVE-Tyson Foods, Atmus Filtration, Avis Budget

Reuters
·
Apr 06

BUZZ-Oncolytics rises as it schedules FDA talks on anal cancer drug

Reuters
·
Apr 06

Oncolytics schedules FDA meeting for pelareorep registrational path

TIPRANKS
·
Apr 06

Oncolytics schedules FDA Type C meeting on single-arm registrational pathway for pelareorep in anal cancer

Reuters
·
Apr 06

Oncolytics Biotech Inc - Schedules Type C FDA Meeting on April 16, 2026 for Pelareorep in Anal Cancer

THOMSON REUTERS
·
Apr 06

Oncolytics Biotech Inc - Meeting to Discuss Single-Arm Pivotal Study of Pelareorep in Second-Line and Later Scac

THOMSON REUTERS
·
Apr 06

Top News Today/Canada: Goods-Trade Deficit Widens, Surplus With U.S. Narrows

Dow Jones
·
Apr 03

Oncolytics completes domicile change to the U.S.

TIPRANKS
·
Apr 01

Oncolytics Biotech shifts headquarters to San Diego, completes Nevada domestication

Reuters
·
Apr 01

Oncolytics files $250M mixed securities shelf

TIPRANKS
·
Apr 01

Oncolytics Biotech Inc - May Offer up to $250 Mln in Aggregate Securities - SEC Filing

THOMSON REUTERS
·
Apr 01

Oncolytics Biotech Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 31

Oncolytics FY25 net loss widens to $ US 29M; operating loss grows to $ US 29M

Reuters
·
Mar 31

Geron appoints Patricia S. Andrews and Constantine Chinoporos to board of directors

Reuters
·
Mar 26

Oncolytics Biotech Showcases Pelareorep as Immune-Priming Backbone With New AACR 2026 Data

TIPRANKS
·
Mar 20